Endovia Health Sciences (EDVA) Property, Plant & Equipment (Net) (2013 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Property, Plant & Equipment (Net) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.50 Bn | 133.65 Bn | 2.84 Bn | 1.67 Bn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | 5.46 Bn |
| 3 | Argenx Se | 65.05 Bn | 59.86 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 57.11 Bn | 51.98 Bn | 52.00 Mn | 2.06 Bn |
| 5 | Revolution Medicines | 44.71 Bn | 44.71 Bn | - | 34.61 Mn |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 1.64 Bn |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn | 554.14 Mn |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | - |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 107.22 Mn |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 10,605.00 |
| Dec 31, 2025 | 12,926.00 |
| Sep 30, 2025 | 93,756.00 |
| Jun 30, 2025 | 130,773.00 |
| Mar 31, 2025 | 167,791.00 |
| Dec 31, 2024 | 22,210.00 |
| Sep 30, 2024 | 241,766.00 |
| Jun 30, 2024 | 274,073.00 |
| Mar 31, 2024 | 312,589.00 |
| Dec 31, 2023 | 349,802.00 |
| Sep 30, 2023 | 385,603.00 |
| Jun 30, 2023 | 423,844.00 |
| Mar 31, 2023 | 461,217.00 |
| Dec 31, 2022 | 489,597.00 |
| Sep 30, 2022 | 556,936.00 |
| Jun 30, 2022 | 509,054.00 |
| Mar 31, 2022 | 542,535.00 |
| Dec 31, 2021 | 569,785.00 |
| Sep 30, 2021 | 561,505.00 |
| Jun 30, 2021 | 601,304.00 |